
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME_L | 310 | 100.0% | 1.12 | 673 | 100.0% |
| upstream partner | # | NT | conns Dm8 | % In | CV |
|---|---|---|---|---|---|
| R7 (L) | 6 | ACh | 81 | 46.6% | 1.2 |
| Dm8 (L) | 1 | Unk | 15 | 8.6% | 0.0 |
| Sm19 (L) | 2 | GABA | 12 | 6.9% | 0.7 |
| Sm20 (L) | 4 | ACh | 8 | 4.6% | 0.6 |
| yDm8 (L) | 3 | GABA | 6 | 3.4% | 0.4 |
| aMe17b (L) | 2 | GABA | 5 | 2.9% | 0.6 |
| L1 (L) | 2 | GABA | 5 | 2.9% | 0.2 |
| Sm08 (L) | 1 | GABA | 4 | 2.3% | 0.0 |
| Sm26 (L) | 1 | ACh | 4 | 2.3% | 0.0 |
| Sm09 (L) | 1 | GABA | 4 | 2.3% | 0.0 |
| Dm2 (L) | 2 | ACh | 4 | 2.3% | 0.0 |
| Tm7 (L) | 1 | ACh | 3 | 1.7% | 0.0 |
| Mi10 (L) | 1 | ACh | 3 | 1.7% | 0.0 |
| aMe5 (L) | 1 | ACh | 2 | 1.1% | 0.0 |
| Sm35 (L) | 1 | GABA | 2 | 1.1% | 0.0 |
| aMe17a2 (L) | 1 | Glu | 2 | 1.1% | 0.0 |
| pDm8 (L) | 2 | Unk | 2 | 1.1% | 0.0 |
| Sm21 (L) | 2 | ACh | 2 | 1.1% | 0.0 |
| Tm2 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| Tm5b (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| Tm5c (L) | 1 | Glu | 1 | 0.6% | 0.0 |
| MTe04 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| Lawf2 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| Mi15 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| Tm31 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| Dm4 (L) | 1 | GABA | 1 | 0.6% | 0.0 |
| Sm24 (L) | 1 | Unk | 1 | 0.6% | 0.0 |
| MTe07 (L) | 1 | ACh | 1 | 0.6% | 0.0 |
| downstream partner | # | NT | conns Dm8 | % Out | CV |
|---|---|---|---|---|---|
| Dm8 (L) | 1 | Unk | 15 | 12.5% | 0.0 |
| Sm19 (L) | 2 | GABA | 10 | 8.3% | 0.8 |
| Dm2 (L) | 4 | ACh | 10 | 8.3% | 0.4 |
| Dm11 (L) | 2 | Unk | 7 | 5.8% | 0.7 |
| Tm5d (L) | 1 | Glu | 6 | 5.0% | 0.0 |
| Tm5f (L) | 3 | ACh | 6 | 5.0% | 0.7 |
| TmY10 (L) | 1 | ACh | 5 | 4.2% | 0.0 |
| R8 (L) | 1 | ACh | 5 | 4.2% | 0.0 |
| Tm31 (L) | 2 | GABA | 5 | 4.2% | 0.2 |
| yDm8 (L) | 4 | GABA | 5 | 4.2% | 0.3 |
| Sm09 (L) | 1 | GABA | 4 | 3.3% | 0.0 |
| Tm7 (L) | 2 | ACh | 4 | 3.3% | 0.5 |
| Mi4 (L) | 2 | GABA | 4 | 3.3% | 0.5 |
| pDm8 (L) | 4 | GABA | 4 | 3.3% | 0.0 |
| Tm5c (L) | 1 | Glu | 3 | 2.5% | 0.0 |
| Sm20 (L) | 2 | ACh | 3 | 2.5% | 0.3 |
| MTe35 (L) | 1 | ACh | 2 | 1.7% | 0.0 |
| Tm37 (L) | 1 | ACh | 2 | 1.7% | 0.0 |
| Dm4 (L) | 1 | GABA | 2 | 1.7% | 0.0 |
| Tm25 (L) | 2 | ACh | 2 | 1.7% | 0.0 |
| Mi9 (L) | 2 | GABA | 2 | 1.7% | 0.0 |
| TmY5a (L) | 2 | Glu | 2 | 1.7% | 0.0 |
| Sm21 (L) | 2 | ACh | 2 | 1.7% | 0.0 |
| MeMe_e11 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| Tm5b (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| TmY9q (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| Sm08 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| Tm4 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| Lawf2 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| Mi10 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| Sm41 (L) | 1 | GABA | 1 | 0.8% | 0.0 |
| MTe01b (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| Tm20 (L) | 1 | GABA | 1 | 0.8% | 0.0 |